We are live on ! Find out more
QCOR

QUESTCOR PHARMA INC
QCOR

Delisted

QCOR was delisted on the 14th of August, 2014.

313 hedge funds and large institutions have $4.06B invested in QUESTCOR PHARMA INC in 2014 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 102 increasing their positions, 125 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 29

18% more capital invested

Capital invested by funds: $3.44B → $4.06B (+$616M)

14% more funds holding in top 10

Funds holding in top 10: 78 (+1)

10% more funds holding

Funds holding: 285313 (+28)

18% less repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 125

44% less call options, than puts

Call options by funds: $256M | Put options by funds: $455M

Holders
313
Holders Change
+28
Holders Change %
+9.82%
% of All Funds
9.04%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.23%
New
58
Increased
102
Reduced
125
Closed
29
Calls
$256M
Puts
$455M
Net Calls
-$199M
Net Calls Change
+$34.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$263M +$7.5M +117,444 +3%
BFA
2
BlackRock Fund Advisors
California
$255M +$5.62M +88,082 +2%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$252M -$93.3M -1,461,400 -27%
SAC
4
Smith Affiliated Capital
New York
$173M
Bank of New York Mellon
5
Bank of New York Mellon
New York
$152M +$18M +282,672 +14%
BC
6
Broadwood Capital
New York
$146M -$34.8M -545,000 -19%
TCIM
7
TIAA CREF Investment Management
New York
$143M +$30.7M +480,386 +28%
Bank of America
8
Bank of America
North Carolina
$123M +$19.2M +300,908 +19%
LSV Asset Management
9
LSV Asset Management
Illinois
$122M -$5.11M -80,049 -4%
State Street
10
State Street
Massachusetts
$112M +$1.68M +26,262 +2%
BIT
11
BlackRock Institutional Trust
California
$97.4M +$743K +11,631 +0.8%
ORI
12
Oak Ridge Investments
Illinois
$92.8M +$2.77M +43,416 +3%
DM
13
Deerfield Management
New York
$67.5M -$29.8M -466,432 -31%
TA
14
Teachers Advisors
New York
$63.2M +$12.1M +189,373 +24%
PAI
15
Palo Alto Investors
California
$62.9M +$351K +5,500 +0.6%
Northern Trust
16
Northern Trust
Illinois
$62.2M +$8.13M +127,292 +15%
JHIU
17
Janus Henderson Investors US
Colorado
$60.7M +$18.8M +294,003 +46%
Invesco
18
Invesco
Georgia
$51.9M +$44.6K +698 +0.1%
Goldman Sachs
19
Goldman Sachs
New York
$51.1M +$2.59M +40,491 +5%
Fidelity International
20
Fidelity International
Bermuda
$47.3M +$46.5M +728,614 New
BBA
21
Baker Bros. Advisors
New York
$46.6M -$3.71M -58,119 -7%
MVP
22
Miller Value Partners
Florida
$43.9M -$54.3K -850 -0.1%
CS
23
Credit Suisse
Switzerland
$43.6M +$17.4M +273,223 +68%
NAP
24
New Amsterdam Partners
New York
$34.1M +$547K +8,566 +2%
VAM
25
Visium Asset Management
New York
$34M +$33.4M +523,000 New

QCOR Hedge Fund Activity: Q1 2014 in Review

313 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in QUESTCOR PHARMA INC (QCOR) for Q1 2014, worth a combined $4.06B — up 18% from $3.44B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new QCOR positions and 29 closed out — a net gain of 29 holders — while 102 added to existing stakes and 125 trimmed.

The largest buyer was Fidelity International, opening a new position worth an estimated $46.5M. The largest seller was Fidelity Investments, cutting an estimated $93.3M.

  • 313 institutional investors held QUESTCOR PHARMA INC (QCOR) as of Q1 2014, up from 285 in Q4 2013.
  • Funds reported $4.06B of QUESTCOR PHARMA INC stock for Q1 2014, up 18% quarter-over-quarter.
  • 58 funds opened new QUESTCOR PHARMA INC positions in Q1 2014 and 29 closed out, a net change of +29 holders.
  • The largest QUESTCOR PHARMA INC buyer in Q1 2014 was Fidelity International, an estimated $46.5M added.
  • The largest QUESTCOR PHARMA INC seller in Q1 2014 was Fidelity Investments, an estimated $93.3M sold.

Based on aggregated 13F filings for Q1 2014.